We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3988:HKEXBank of China Limited Class H Analysis

Data as of 2026-06-06 - not real-time

HK$5.31

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Bank of China (3988.HK) trades at a **PE of 6.17**, well below the industry average of 17, and a **price‑to‑book of 0.54** versus a book value of HK$9.81 per share, indicating a deep valuation discount. The stock is supported by a **high dividend yield of 4.76%** and a modest **payout ratio of 31%**, suggesting dividend sustainability despite negative operating cash flow. Technically, the **20‑day SMA (5.224) sits above the 50‑day SMA (5.111) and the 200‑day SMA (4.639)**, confirming a bullish trend, while the **RSI at 60** points to room for upside without being overbought. The price is near the **support level of 5.06** and below the **resistance of 5.33**, offering a potential bounce with an estimated **upside of 17%** based on analyst targets. Low **beta (0.107)** and a **30‑day volatility of 16.4%** imply limited price swings, and the **fear‑greed index at 83 (Extreme Greed)** reflects strong market appetite. Overall, the combination of strong fundamentals, attractive yield, and favorable technical setup positions the stock as an **undervalued, value‑oriented investment** with upside potential.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish SMA crossover indicating momentum
  • Price near support with upside to resistance
  • Attractive dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation discount to peers
  • Analyst target price implying ~17% upside
  • Stable dividend and low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Exposure to Chinese regulatory and macroeconomic environment
  • Sustained dividend income
  • Potential pressure from negative operating cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin43.26%
P/E Ratio6.2
ROE8.37%
ROA0.69%
P/B Ratio0.5
Op. Cash FlowHK$-543587008512
Industry P/E17.0

Technical Analysis

TrendBullish
RSI60.4
SupportHK$5.06
ResistanceHK$5.33
MA 20HK$5.22
MA 50HK$5.11
MA 200HK$4.64
MACDBearish
VolumeStable
Fear & Greed Index83.02

Valuation

Target PriceHK$6.21
Upside/Downside16.95%
GradeUndervalued
TypeValue
Dividend Yield4.76%

Risk Assessment

Beta0.40
Volatility16.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.